I've thought about this and the many pressures that multiple governments could put on CYDY, including our own. Trump could easily bully us. It would be much harder for him to do the same to a major pharma company.

If South Korea attempted something like that, one phone call would resolve it....and very quickly.

Fortunately, they are doing much better than other countries. I believe Leronlimab will be prioritized to the sickest patients first while manufacturing ramps up even more. I think our CEO has already initiated a major ramp up. Also, remember we have another manufacturer that has production capabilities here.